Is Hikma Pharmaceuticals the next takeover target in the pharmaceutical sector?
The boys over The Motley Fool certainly seem to think so.
A cheeky financial blog with stories about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. [Disclaimer - the information on Betaville does not constitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions.]
Showing posts with label Motley Fool. Show all posts
Showing posts with label Motley Fool. Show all posts
Tuesday, 6 May 2014
Subscribe to:
Comments (Atom)